HYPE3 — Analyst Estimates

HYPERA S.A. (HYPE3), Pharmaceuticals. Sell-side consensus tracked weekly by Oak Research: price target range and median, analyst count, rating distribution, forward revenue and EPS estimates with revisions, and expected versus reported EPS by quarter. Source: public consensus feed (Yahoo Finance); photographs are stored weekly, so revision history builds over time.

Company page · Company Data · Methodology